Interface to Participate in the Jefferies Virtual Industrials Conference
Get Alerts TILE Hot Sheet
Join SI Premium – FREE
ATLANTA, July 30, 2021 /PRNewswire/ -- Interface, Inc. (Nasdaq: TILE), a worldwide commercial flooring company and global leader in sustainability, today announced that Dan Hendrix, Chief Executive Officer, and Bruce Hausmann, Chief Financial Officer, will present virtually at the annual Jefferies Virtual Industrials Conference on Tuesday, August 3, 2021 at 9:30 a.m. ET.
The presentation will be available via webcast, which can be accessed through the Events tab in the Investor Relations section of the Company's website at www.investors.interface.com, or at https://wsw.com/webcast/jeff190/tile/1849126. A replay of the webcast will be available on the Company's website following the conclusion of the presentation.
About Interface
Interface, Inc. is a global flooring company specializing in carbon neutral carpet tile and resilient flooring, including luxury vinyl tile (LVT) and nora® rubber flooring. We help our customers create high-performance interior spaces that support well-being, productivity, and creativity, as well as the sustainability of the planet. Our mission, Climate Take Back™, invites you to join us as we commit to operating in a way that is restorative to the planet and creates a climate fit for life.
Learn more about Interface at interface.com and blog.interface.com, our nora brand at nora.com, our FLOR® brand at FLOR.com, and our Carbon Neutral Floors™ program at interface.com/carbonneutral. Learn more about our carbon negative products at interface.com/carbonnegative.
Follow us on Twitter, YouTube, Facebook, Pinterest, LinkedIn, Instagram, and Vimeo.
View original content to download multimedia:https://www.prnewswire.com/news-releases/interface-to-participate-in-the-jefferies-virtual-industrials-conference-301345085.html
SOURCE Interface, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ping An Unveils Innovative AI Solutions in Healthcare, Insurance and Payments at WAIC 2026
- Innate Pharma Announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-drug Conjugate (ADC)
- Publication of the Q2 2026 financial results on Thursday, July 30, 2026, after market close
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Jefferies & Co, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share